Siddhartha C. Kadia
Chief Executive Officer
Business and Management
EAG Laboratories
United States of America
Biography
Prior to EAG, Siddhartha served as the President of the Life Sciences Division of Life Technologies Corporation where he was responsible for worldwide P&L of a $2B of portfolio, which included many differentiated technologies, including proprietary reagents franchises and a bioproduction business. Industry leading brands including Invitrogen, GIBCO, Dynal, Ambion, Molecular Probes and Novex were part of this portfolio. Previously, Siddhartha served in various executive roles at Life Technologies, including President , Life Technologies Greater China (2011-2013), President, Life Technologies Japan Ltd. (2009-2011) and Chief Marketing Officer (2008-2009). He also served on the Board for Life Technologies Foundation and on the Board of Life Technologies DaAn Diagnostics, a China-based joint venture he established. From July 2005 to July 2008, he served in numerous roles at Invitrogen Corporation, including Vice President, Global Marketing and eBusiness. Invitrogen merged with Applied Biosystems, Inc. in 2008 to form Life Technologies.
Research Interest
Business and Management
